Recent studies have indicated that Staphylococcus aureus can survive the nitrosative stress (caused by the radical nitric oxide; NOÁ) mounted by the immune system of the infected host. It does this by expressing a nitric oxideinducible l-lactate dehydrogenase (Sa-LDH-1). Therefore, if efficient inhibitors of Sa-LDH-1 can be designed then Sa-LDH-1 could be a potential drug target against the pathogen S. aureus. For this purpose, the nitric acid-inducible LDH-1 from S. aureus COL strain has been cloned into the expression vector pET-28a(+) and the protein has been expressed, purified and crystallized. The Sa-LDH-1 crystal diffracted to 2.4 Å resolution at a home X-ray source and belonged to space group C2, with unit-cell parameters a = 131.4, b = 74.4, c = 103.2 Å , = 133.4 .
Introduction
Lactate dehydrogenase (EC 1.1.1.27), a member of the 2-hydroxyacid oxidoreductase family, is essential for all organisms and has been intensively studied. The enzyme catalyzes the stereospecific conversion of lactate to pyruvate and converts NAD + to NADH. This reaction is an important way of regenerating NAD + , enabling the continuation of glycolysis (Garvie, 1980) . Pathogenic Staphylococcus aureus is resistant to the human innate immune system, which produces the antimicrobial radical nitric oxide (NOÁ); this is the first line of host defence using the inhibition of bacterial respiration by NOÁ (Fang, 2004) . Recent studies have shown that the mechanism by which S. aureus survives host nitrosative stress is by the expression of an NOÁ-inducible l-lactate dehydrogenase (Sa-LDH-1; Richardson et al., 2008) . Therefore, if we are able to design and screen for selective inhibitors then Sa-LDH-1 could become a potential drug target for new antibiotics. To gain insight into the structural differences between the LDH isoforms from S. aureus and to compare them with human LDH for structure-based drug design and to screen specific inhibitors for drug discovery, the high-resolution structure of Sa-LDH-1 is needed. Pathogenic S. aureus contains two structurally undetermined l-lactate dehydrogenases with 53% sequence identity to each other: the NOÁ-inductive Sa-LDH-1 and the housekeeping constitutive Sa-LDH-2 (Richardson et al., 2008) .
Here, we report the cloning, purification, crystallization and preliminary X-ray crystallographic analysis of Sa-LDH-1.
Materials and methods

Cloning and expression
The gene ldh-1 was amplified from the genomic DNA of S. aureus COL strain by polymerase chain reaction (PCR) using the forward primer 5 0 -CGCGGATCCATGAACAAATTTAAAGGGAACAA-AG-3 0 and the reverse primer 5 0 -CCCAAGCTTTTATTTAAGTTC-TTCTGCTTCAGCC-3 0 containing BamHI and HindIII digestion site, respectively. After digestion by BamHI and HindIII at 298 K for 4 h, the PCR product was ligated into the expression vector pET-28a(+) (Novagen, USA) containing an N-terminal His 6 tag at 277 K overnight. The sequence of the recombinant vector was verified by DNA sequencing.
The recombinant vector containing the target gene was transformed into Escherichia coli BL21 Rosetta strain (Invitrogen, USA). The transformed cells were grown overnight at 310 K in 20 ml Luria-Bertani (LB) broth medium containing 50 mg ml À1 kanamycin. The overnight cultures were then inoculated into 1 l fresh LB medium containing 50 mg ml À1 kanamycin and grown at 310 K until the OD 600 reached 0.6-0.8. The cells were then induced with 1.0 mM isopropyl -d-1-thiogalactopyranoside. After further growth at 291 K overnight, the cells were harvested by centrifugation at 6000g for 10 min and resuspended in lysis buffer (20 mM Tris-HCl, 500 mM NaCl pH 7.5).
Protein purification and crystallization
The resuspended cells were disrupted by sonication on ice and centrifuged at 34 700g for 20 min twice. The supernatant was loaded onto a 5 ml Ni 2+ -chelating affinity column (HiTrap; GE Healthcare, USA) previously equilibrated with lysis buffer. The column was eluted with a linear gradient of imidazole from 0.0 to 0.5 M in lysis buffer. The fractions containing the target protein were further purified by gel filtration using a Superdex 75 XK 16/60 gel-filtration column (GE Healthcare, USA) with elution buffer (20 mM Tris-HCl, 200 mM NaCl pH 7.5). The purity of the target protein was verified by SDS-PAGE as shown in Fig. 1 .
The purified Sa-LDH-1 protein was concentrated to 15 mg ml À1 in the final elution buffer using a Millipore centrifugal filter device (Ultra-15, 10 kDa cutoff; Millipore, USA). Crystallization experiments were carried out at 289 K using the sitting-drop vapourdiffusion method in a 48-well plate (XtalQuest Inc., Beijing, People's Republic of China). Crystallization screening kits such as Crystal Screen, Crystal Screen 2 and Index (Hampton Research, California, USA) were used as initial screening conditions. 1 ml protein solution was mixed with an equal volume of reservoir solution and equilibrated against 100 ml reservoir solution. Thin crystal plates of equilateral triangular shape appeared in Crystal Screen condition No. 14 [0.2 M calcium chloride dihydrate, 0.1 M Na HEPES pH 7.5, 28%(v/v) PEG 400] after 3 d. Single crystals (Fig. 2 ) of diffraction quality were obtained when the protein concentration was reduced to 5 mg ml À1 .
Data collection and procession
One crystal was picked up in a nylon loop, flash-cooled immediately without further cryoprotection in liquid nitrogen, mounted and maintained at 100 K in a cold nitrogen-gas stream during data collection. X-ray diffraction data were collected from a single crystal on a Bruker SMART 6000 CCD detector using in-house Cu K radiation from a Bruker Microstar-H rotating-anode generator operated at 45 kV and 40 mA. The crystal-to-detector distance was set to 6.00 cm. 1500 frames were collected with 0.3 ' oscillation and an exposure time of 120 s per frame. Diffraction data were processed using the online Bruker PROTEUM software suite (Bruker AXS; http://www.bruker-axs.de/software4.html).
Results and discussion
Essentially, only one thick band was visible on SDS-PAGE stained by Coomassie Blue after size-exclusion chromatography purification of Sa-LDH-1 with overloaded samples as shown in Fig. 1 , indicating a high degree of protein purity. The purified protein had an estimated molecular mass of about 39 kDa, which is in agreement with the predicted molecular mass of 34.6 kDa plus an additional 4 kDa N-terminal His 6 -tag fusion peptide. SDS-PAGE of Sa-LDH-1 during purification. The left part shows fractions containing the target protein eluted from the Ni 2+ -chelating affinity column. The right part shows the protein further purified using a Superdex 75 gel-filtration column.
Figure 2
Crystals of Sa-LDH-1 from S. aureus have equilateral triangular shapes with typical dimensions of 0.5-0.8 mm on the edges and 0.1-0.2 mm in thickness.
Figure 3
Diffraction pattern of Sa-LDH-1 collected using a home X-ray source (Bruker Microstar-H system) with resolution rings.
The crystals obtained from 0.2 M calcium chloride dihydrate, 0.1 M Na HEPES pH 7.5, 28%(v/v) PEG 400 were equilateral triangular plates of about 0.6 mm on the edges and 0.1 mm in thickness (Fig. 2) . The crystals diffracted to beyond 2.2 Å resolution (a typical diffraction pattern is shown in Fig. 3 ) and belonged to space group C2. A data set was collected to 2.4 Å resolution with unit-cell parameters a = 131.4, b = 74.4, c = 103.2 Å , = 133.4 . Data statistics are summarized in Table 1 . Assuming the presence of two molecules per asymmetric unit, the Matthews coefficient is 2.54 Å 3 Da À1 (Matthews, 1968) and the solvent content is 51.7%. Structure determination is under way by molecular replacement. LDH from Bacillus stearothermophilus (PDB code 1ldn; Wigley et al., 1992) will be used as the search model in molecular replacement. 
